Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinomaThanos P. Mourikis, Shaun R. Preston, Michael Howell et al.|Nature Communications|2019Cited by 49
Mutational signature dynamics shaping the evolution of oesophageal adenocarcinomaSujath Abbas, Andrew Davies, Oriol Pich et al.|Nature Communications|2023Cited by 25
Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancerPiyali Ganguli, Andrew D. Beggs, Celia De Los Angeles Colomina Basanta et al.|Nature Cancer|2025Cited by 19
Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomasAlvin Wei Tian Ng, Jesper Lagergren, Gianmarco Contino et al.|Communications Biology|2022Cited by 17